KRAS MUTANT METASTATIC COLORECTAL CANCER

Clinical trials for KRAS MUTANT METASTATIC COLORECTAL CANCER explained in plain language.

Never miss a new study

Get alerted when new KRAS MUTANT METASTATIC COLORECTAL CANCER trials appear

Sign up with your email to follow new studies for KRAS MUTANT METASTATIC COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First human trial launches for experimental cancer 'Breaker' drug

Disease control Recruiting now

This is the first human study testing a new experimental drug called BBO-10203 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goal is to find safe doses and see how the body processes the drug, both alone and when combined with oth…

Matched conditions: KRAS MUTANT METASTATIC COLORECTAL CANCER

Phase: PHASE1 • Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

KRAS MUTANT METASTATIC COLORECTAL CANCER

Get alerted when new KRAS MUTANT METASTATIC COLORECTAL CANCER trials appear

First human trial launches for experimental cancer 'Breaker' drug